STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

  1. Home
  2. Sec-filings
  3. TOVX
  4. [ARS] Theriva Biologics, Inc. SEC Filing

[ARS] Theriva Biologics, Inc. SEC Filing

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - Theriva Biologics, Inc.

ARS Filing - Theriva Biologics, Inc.

This filing is available as a PDF document.

Filing Type: ARS

Company: Theriva Biologics, Inc. (TOVX)

Acceptance Date: 2025-07-09T16:55:51.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Stock TOVX logo
THERIVA BIOLOGICS INC

NYSE:TOVX

TOVX Rankings

#6424 Ranked by Market Cap
N/A Ranked by Dividends

TOVX Latest News

Nov 12, 2025
Theriva™ Biologics Reports Third Quarter 2025 Operational Highlights and Financial Results
Oct 24, 2025
Theriva Biologics Provides Response to Unusual Market Action
Oct 16, 2025
Theriva™ Biologics Announces a Warrant Inducement Transaction for $4.0 Million in Gross Proceeds
Oct 13, 2025
Theriva™ Biologics Announces Upcoming Presentations at Medical Meetings
Oct 6, 2025
Theriva™ Biologics Announces Presentation Describing Next Generation Oncolytic Adenovirus VCN-12 at the 32nd Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)

TOVX Latest SEC Filings

Dec 3, 2025
[424B5] Theriva Biologics, Inc. Prospectus Supplement (Debt Securities)
Nov 12, 2025
[10-Q] Theriva Biologics, Inc. Quarterly Earnings Report
Nov 12, 2025
[8-K] Theriva Biologics, Inc. Reports Material Event
Nov 10, 2025
[SCHEDULE 13G] Theriva Biologics, Inc. SEC Filing
Nov 10, 2025
[DEF 14A] Theriva Biologics, Inc. Definitive Proxy Statement

TOVX Stock Data

8.15M
32.96M
0.14%
12.32%
5.19%
Biotechnology
Pharmaceutical Preparations
Link
United States
ROCKVILLE